title: Update on TIVA.
authors.affiliation: Royal Children's Hospital, Parkville, Victoria, Australia. rob.eyres@rch.org.au
authors.forename: Rob
authors.initials: R
authors.lastname: Eyres
mesh_terms: D000293:Adolescent; D000367:Age Factors; D000771:Anesthesia, Intravenous / Q000379:methods*; D018686:Anesthetics, Intravenous / Q000009:adverse effects / Q000493:pharmacokinetics; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous / Q000295:instrumentation; D010372:Pediatrics; D010880:Piperidines / Q000009:adverse effects / Q000493:pharmacokinetics; D015742:Propofol / Q000009:adverse effects / Q000493:pharmacokinetics; D000077208:Remifentanil
chemical_list: D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil; D015742:Propofol